Bronchoectatic disease: the state of art and the clinical case.

Authors

DOI:

https://doi.org/10.26641/2307-0404.2018.3(part1).142360

Keywords:

bronchoectatic disease, bronchiectasis, computed tomography, Pseudomonas aeruginosa

Abstract

In connection with the increased diagnostic capabilities of X-ray methods, bronchiectasis is increasingly being diagnosed today. The main problem of patients’ management is the heterogeneity of the etiological factors, as well as the lack of evidence base for the effectiveness of therapy. The article presents a clinical case of bronchiectasis in a patient with chronic carriage of Pseudomonas aeruginosa (mucoid strain) and Klebsiella pneumoniae.

Author Biographies

T. O. Pertseva

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of occupational diseases and clinical immunolog
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

K. Yu. Gashynova

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of occupational diseases and clinical immunolog
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

V. V. Dmytrychenko

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of occupational diseases and clinical immunolog
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

K. S. Suska

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of occupational diseases and clinical immunolog
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

References

Pertseva TA, Kireyeva TV, Krykhtina MA. [Cur­rent view on pharmacotherapy of low respiratory tract infections: the place for macrolides]. Ukrayinskyi pulmo­nologichnyi zhurnal. 2015;3:49-55. Ukrainian.

Samsonova MV. [Bronchiectasis: a modern view of the problem]. Prakticheskaya pulmonologiya. 2017;1:75-76. Russian.

Feshchenko YuI, Dzyublik AYa. [Rational anti­biotic therapy of patients with infections of lower respiratory ways]. Ukrayinskyi pulmonologichnyi zhur­nal. 2009;4:5-8. Russian.

Aliberti S, Lonni S, Dore S et al. Clinical phenotypes in adult patients with bronchiectasis. Eur Res­pir J. 2016 Apr;47(4):1113-22. http://dx.doi.org/10.1183/­13993003.01899-2015

Miguel Angel, Martínez-García MD, Juan-Jose Soler-Cataluña MD et al. Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis. Chest. 2007Nov;132(5):1565-72.

Barker AF. Bronchiectasis. N. Engl. J. Med. 2002;346(18):1383-93. http://dx.doi.org/10.1056/NEJMra­012519

Luce Cantin, Alexander A Bankier, and Ronald L. Eisenberg. Bronchiectasis. American Journal of Roent­genology. 2009;193:158-71.

Chang AB, Grimwood K, Mulholland EK et al. Bronchiectasis in Indigenous children in remote Austra­lian communities. Med J. Aust. 2002;177:200-4.

McDonnell MJ, Aliberti S, Goeminne PC et al. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax. 2016;71:1110-8. http://dx.doi.org/10.1136/thoraxjnl-2016-208481

Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, Polverino E, Van de Kerk­hove C, Rutherford R, Davison J et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12(12):1764-70. http://dx.doi.org/10.1513/­AnnalsATS.201507-472OC

Finch S, McDonnell MJ, Abo-Leyah H et al. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchi­ectasis. Ann Am Thorac Soc. 2015;12:1602-11.

Finklea JD, Khan G, Thomas S et al. Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis. Respir Med. 2010;104:816-21. http://dx.doi.org/10.1016/j.rmed.2009.11.021

Kwak HJ, Moon J-YY, Choi YW et al. High pre­valence of bronchiectasis in adults: analysis of CT fin­dings in a health screening program. Tohoku J Exp Med. 2010;222:237-42. http://dx.doi.org/10.1620/tjem.222.237

Loebinger MR, Wells AU, Hansell DM et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009;34:843-9. http://dx.doi.org/10.1183/09031936.00003709

Kyreeva T, Dmytrychenko V, Pertseva T, Bogats­ka K. Microbial landscape of sputum in patients with non-cystic fibrosis bronchiectasis. 2nd World Bronchiectasis Conference. 2017;52.

Mirsaeidi M, Hadid W, Ericsoussi B et al. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. International Journal of Infectious Diseases. 2013;17:1000-4. http://dx.doi.org/10.1016/j.ijid.2013.03.018.

Moulton BC, Barker AF. Pathogenesis of bronchiectasis. Clin Chest Med. 2012;33(2):211-7. http://dx.doi.org/10.1016/j.ccm.2012.02.004

Orriols R, Hernando R, Ferrer A et al. Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Respiration. 2015;90:299-305. http://dx.doi.org/10.1159/000438490

Polverino E, Goeminne PC, McDonnell MJ et al. European Respiratory Society guidelines for the ma­nagement of adult bronchiectasis. Eur Respir J. 2017;50. http://dx.doi.org/10.1183/13993003.00629-2017

Quint JK, Millett ER, Joshi M et al. Changes in the incidence, prevalence and mortality of bronchi­ectasis in the UK from 2004 to 2013: A population-based cohort study. Eur Respir J. 2016;47:186-193. http://dx.doi.org/10.1183/13993003.01033-2015

Rademacher J, Welte T. Bronchiectasis – diag­nosis and treatment. Deutsches Aerzteblatt Online. 2011;108:809-15.

Raghu G, King TE, Behr J et al. Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1). Eur Respir J. 2010;35:118-23. http://dx.doi.org/10.1183/09031936.00188108.

Ringshausen FC, de Roux A, Pletz MW et al. Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. PLoS One. 2013;8:e71109. http://dx.doi.org/10.1371/journal.pone.0071109

Seitz AE, Olivier KN, Steiner CA et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest. 2010;138:944-9. http://dx.doi.org/10.1378/chest.10-0099

Pamela J McShane, Edward T Naureckas, Gregory Tino et al. Non–Cystic Fibrosis Bronchiectasis. AJRCCM. 2013 Sept;188:6.

Yu-xing Jin, Yi Zhang, Liang Duan, Yang Yang, Ge-ning Jiang, Jia-an Ding. Surgical treatment of bronchi­ectasis: A retrospective observational study of 260 patients. International Journal of Surgery. 2014;12(10):1050-4. http://dx.doi.org/10.1016/j.ijsu.2014.08.398

Tashkin DP, Celli B, Senn S et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543-54. http://dx.doi.org/10.1056/NEJMoa0805800

Thurlbeck WM. Chronic airflow obstruction. Thurlbeck pathology of the lung 2nd edition. 1995;804-8.

Weycker D, Edelsberg J, Oster G et al. Preva­len­ce and economic burden of bronchiectasis. Clin Pulm Med. 2005;12:205-9. http://dx.doi.org/10.1097/01.cpm.0000171422.98696.ed.

How to Cite

1.
Pertseva TO, Gashynova KY, Dmytrychenko VV, Suska KS. Bronchoectatic disease: the state of art and the clinical case. Med. perspekt. [Internet]. 2018Oct.26 [cited 2024Mar.29];23(3(part1):153-61. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/142360

Issue

Section

THEORETICAL MEDICINE